Neuropharmacology and Neurotoxicologyα-Lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicityAguirre, Norberto1; Barrionuevo, Meritxell1; Ramírez, María J.1; Río, Joaquín Del1; Lasheras, Berta1,2 Author Information 1Department of Pharmacology, School of Medicine, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain 2Corresponding Author: Berta Lasheras ACKNOWLEDGEMENTS: This study was supported by EC, BIO4 CT96-0752. Received 21 July 1999; accepted 16 September 1999 NeuroReport: November 26, 1999 - Volume 10 - Issue 17 - p 3675-3680 Buy Abstract A single administration of 3,4-methylenedioxymetham-phetamine (MDMA, 20 mg/kg, i.p.), induced significant hyperthermia in rats and reduced 5-hydroxytryptamine (5-HT) content and [3H]paroxetine-labeled 5-HT transporter density in the frontal cortex, striatum and hippocampus by 40–60% 1 week later. MDMA treatment also increased glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampus. Repeated administration of the metabolic antioxidant α-lipoic acid (100 mg/kg, i.p., b.i.d. for 2 consecutive days) 30 min prior to MDMA did not prevent the acute hyperthermia induced by the drug; however, it fully prevented the serotonergic deficits and the changes in the glial response induced by MDMA. These results further support the hypothesis that free radical formation is responsible for MDMA-induced neurotoxicity. © 1999 Lippincott Williams & Wilkins, Inc.